Shows
Pet let pozneje13. epizoda, sir Peter Horby: Vse se lahko ponovi že jutriEpidemiolog svetovnega slovesa profesor Peter Horby vodi Inštitut za pandemične znanosti Univerze v Oxfordu, je tudi svetovalec britanske vlade in Svetovne zdravstvene organizacije. Za svoje raziskovalno delo je leta 2021 prejel viteški naziv. Sir Peter Horby, s katerim se je v Oxfordu o pomenu znanosti, epidemijah, raziskovanju, rezultatih, iskanju učinkovitih zdravil ter pridobljenih izkušnjah pogovarjala radijska novinarka Mojca Delač, je posebej poudaril: "Znanstveniki in znanost smo rešili milijone življenj."V epizodah podkasta Pet let pozneje, ki jih pripravlja Tatjana Pirc, se vrstijo pogovori in prispevki o izkušnjah, spoznanjih in posledicah pandemije covida-19, ki se je zač...2025-04-0442 min
Peter prepperLynkursus fra en jægersoldat.Peter Falktoft er overbevist. De originale preppere må være de danske elitesoldater, som er toptrænet til fingerspidserne. I denne episode får han besøg af jægersoldaten Jesper Hørby, som endte i en personlig katastrofesituation, som nær kostede ham livet. Men hvilke redskaber fik Jesper så helskindet som muligt gennem krisen? Hvad gjorde ham robust under et umenneskeligt pres? Og hvordan kan vi almindelige danskere tilgå prepping som en jægersoldat?
GÆST: Jesper Hørby, jægersoldat.
Produceret for DR af PodAmok.2024-08-0540 min
The Oxford ColloquyThe Pandemic People: Sir Peter HorbySir Andrew Pollard talks to Sir Peter Horby, Professor of Emerging Infectious Diseases and Director of the Pandemic Sciences Institute at Oxford. He is Co-Chief investigator of the RECOVERY trial of drug treatments for COVID. Peter Horby talks about his early medical career working with HIV patients in hospitals. He talks about his background in infectious diseases and public health. His work in researching treatments for infectious diseases led to working abroad on tropical diseases and public health. He talks about being part of the outbreak response team in Vietnam for the SARS-1 virus outbreak which had a high mortality ra...2024-02-0240 min
MotivAtt skapa ett monster - Del 6/8 “Offerlammet”Alexander söker råd hos advokat Peter Althin och går igenom DNA-beviset från mordutredningen om Hélen Nilsson. Vi får veta i detalj vad som hände kvällen då Hélen försvann från Hörby.Mysteriet med tidpunkten för Hélens död öppnar upp utredningen i en ny riktning.“Att skapa ett monster” är en serie i åtta delar av Alexander Mork. Exekutiv producent: Nils Bergman. Ansvarig utgivare: Jonas Häger. Förhandslyssna på hela serien direkt via Motiv+På attskapaettmonster.se kan ni själva fördjupa er y...2023-04-051h 08
Collecting COVID: Oral HistoriesProfessor Martin LandrayGeorgina Ferry interviews Martin Landray, Professor of Medicine and Epidemiology, 27 October 2022. Topics discussed include (00:00:19) early interest in medicine and medical school at University of Birmingham, interest in clinical pharmacology, clinical lectureship at Birmingham and attainment of PhD, interest in clinical trials, the work of Richard Peto and Rory Collins on randomised trial at Oxford; (00:15:29) The Heart Protection Study and work in the Clinical Trial Service Unit; (00:22:22) work designing clinical trials, including relating to lowering cholesterol in people with kidney disease and work with Louise Bowman; (00:25:30) changes to rules and regulations around modern clinical trials; (00:40:09) first awareness of COVID-19, early discussions...2023-03-301h 27Collecting COVID: Oral HistoriesProfessor Martin LandrayGeorgina Ferry interviews Sir Martin Landray, Professor of Medicine and Epidemiology, 27 October 2022. Topics discussed include (00:00:19) early interest in medicine and medical school at University of Birmingham, interest in clinical pharmacology, clinical lectureship at Birmingham and attainment of PhD, interest in clinical trials, the work of Richard Peto and Rory Collins on randomised trial at Oxford; (00:15:29) The Heart Protection Study and work in the Clinical Trial Service Unit; (00:22:22) work designing clinical trials, including relating to lowering cholesterol in people with kidney disease and work with Louise Bowman; (00:25:30) changes to rules and regulations around modern clinical trials; (00:40:09) first awareness of COVID-19, early...2023-03-301h 27Collecting COVID: Oral HistoriesProfessor Richard CornallGeorgina Ferry interviews Richard Cornall, Head of the Nuffield Department of Medicine, 26 October 2022. Topics discussed include (00:00:18) early interest in medicine, including medical school at Cambridge, further studies and work at Oxford, interest in immunology and work at Stanford as a researcher, clinical training at Oxford; (00:02:20) research relating to diabetes, interest in autoimmune diseases and immunology, work with Simon Davis relating to the creation of drugs to combat disease; (00:04:30) treatment for cancers using blockers for checkpoint receptors; (00:08:02) work as the Head of Nuffield Department of Medicine; (00:11:00) work of the department, particularly infectious disease and tropical medicine, including global research units; (00:14:52) division...2023-03-301h 38
Science with SanjulaSaving over a million lives around the worldProfessor Sir Peter Horby, Moh Foundation Professor of Infectious Diseases and Director of the University of Oxford’s Pandemic Sciences Institute, describes how he came to study medicine following his initial interest in biology and how his first job on the HIV/AIDS wards led to his interest in infectious diseases. Professor Sir Horby describes his time working with the World Health Organisation in Vietnam on the SARS-CoV-1 outbreak and subsequently setting up an infectious diseases research unit in Hanoi, his work on the West Africa Ebola epidemic, and how he adapted his skills for a higher income setting to c...2023-02-2821 minCollecting COVID: Oral HistoriesProfessor John Bell (part one)Georgina Ferry interviews Sir John Bell, Regius Professor of Medicine, 22 February 2022. Topics discussed include (00:00:18) JB's early interest and training in medicine, work with Sir David Weatherall, studies as Rhodes Scholar at Oxford and Stanford and later work at Oxford including as Nuffield Chair of Medicine and Regius Professor of Medicine; (00:01:10) interest in the mechanisms of different diseases and molecular medicine; (00:02:12) the evolution and expansion of medicine at Oxford; (00:07:05) involvement in public and national bodies, including the Academy of Medical Sciences, the Office for Strategic Coordination of Health Research, Roche and work with David Cooksey; (00:12:44) nomination as Life Sciences Champion for...2022-11-0249 minCollecting COVID: Oral HistoriesProfessor Peter HorbyGeorgina Ferry interviews Sir Peter Horby, Professor of Emerging Infectious Diseases, 6 December 2021. Topics discussed include (00:00:45) PH's early training in medicine, interest in biology and infectious diseases; (00:02:38) PH's first job working on a HIV ward at Middlesex Hospital and later the Hospital for Tropical Diseases in London, work in Vietnam on SARS-1 in 2003 and in Hanoi for the World Health Organisation, work with Jeremy Farrar particularly with regards to opening the National Hospital of Tropical Diseases; (00:05:22) main threats for Vietnam, in terms of infectious disease outbreaks, work with Professor Liam, resurgence of H5N1 bird flu in 2003-4; (00:07:34) controls required to...2022-07-291h 13
Nuacht Mhall2 Deireadh Fómhair 2021 (Tír Eoghain)Nuacht Mhall. Príomhscéalta na seachtaine, léite go mall.
*
Inniu an dara lá de mhí Dheireadh Fómhair. Is mise Niall Ó Siadhail.
Táthar ag súil go dtiocfadh le druga trialach nua ráta cur in ospidéal nó fiú ráta báis mar gheall ar Covid-19 a laghdú faoina leath. Tugadh an táibléad d'othair a raibh an víreas orthu dhá uair sa lá agus bhí na torthaí chomh dearfach gur stop siad an triail go luath. Anois tá an comhlacht cogaisíochta ag iarraidh cead an druga a úsáid i gcás é...2021-10-0204 min
5th World Sepsis Congress: Sepsis Research and Innovations61: WSC 2021 – Impactful Trials and Innovative Trial Design in Sepsis and COVID-19Session ‘Impactful Trials and Innovative Trial Design in Sepsis and COVID-19’ from the World Sepsis Congress 2021. Featuring Kathy Rowan, François Lamontagne, Anthony Gordon, Luciano Azevedo, Peter Horby, Tomoko Fujii, and Flavia Machado as moderator.
More info: worldsepsiscongress.org2021-06-011h 35
University of OxfordMartin Landray on the RECOVERY trialProfessor Martin Landray details how the RECOVERY trial was born in days and produced results weeks later.
[Image (C) John Cairns, of Professors Martin Landray and Peter Horby outside their Oxford office]2021-05-2002 min
Inside HealthRecovery TrialThis is the remarkable story of how the UK’s Recovery Trial saved the lives of hundreds of thousands of Covid patients. It was set up in nine days, after a conversation on the number 18 bus. Within 100 days it had found the first life-saving drug. This trial has united thousands of doctors, the NHS and 40,000 patients, at the scariest moments of their lives, changing the pandemic, and possibly medicine, forever. We speak to Oxford professors Martin Landray and Peter Horby who devised the Recovery Trial, and to some of the doctors and patients who helped ma...2021-03-2327 min
MINUTO COVID-19Episódio 9: Opções de tratamento para Covid-19 parte 1Esse episódio 9 é direcionado a primeira parte de uma avaliação crítica das opções de tratamento que estão sendo propostas contra a Covid-19. Se você realmente quer saber o que está sendo validado do ponto de vista científico e sem achismos, aperte no "Play" e escute com atenção!
Dúvidas ou sugestões: @minutocovid_19
REFERÊNCIAS:
BRASIL. Agência Nacional de Vigilância sanitária (Anvisa). Nota de esclarecimento sobre a ivermectina. Brasília, 10 julho 2020. Disponível em: http://portal.anvisa.gov.br/noticias/-/asset_publisher/FXrpx...2020-09-0404 min
Coronavirus UK: LBC Update with Nick FerrariBreakthrough drug approved!Nick is joined by Health Secretary Matt Hancock to talk about the breakthrough drug Dexamethasone which has provided some positive results. Mr Hancock also shares his concerns over the suspected second wave of coronavirus cases in Beijing. Nick also speaks to one of the chief investigators for the Dexamethasone trial, who joined Boris Johnson at yesterday's Downing Street briefing, Professor of Emerging Infectious Diseases at the University of Oxford's Nuffield Department of Medicine Peter Horby.
Plus should shielding come to an end in July? Ceri Smith, Head of Policy and Campaigns at disability equality charity Scope shares her thoughts2020-06-1700 min
Unexpected ElementsCovid -19 how infectious is it really?Covid- 19 cases seem to be multiplying daily and there is now a growing body of scientific evidence both on its spread and the effectiveness of measures to try and control it. We look at what’s working, what’s not and why. And we look to the potential for coronavirus drug treatments, why despite the hype there really isn’t anything round the corner.Australia’s recent fire season was intense; a new study looks back over 500 years of the weather pattern partly responsible, the Indian Ocean Dipole. The findings show the most extreme years occurred...2020-03-151h 07
CrowdScienceWhat are scientists doing about coronavirus?Since the outbreak of a new strain of coronavirus late last year, health workers and governments have been rushing to limit transmission by deploying containment tactics and anti-contamination campaigns. But, as the virus spreads around the world, what are scientists doing to help our bodies fight off or resist this new infectious disease?
Viruses that cause human disease can be notoriously tricky to tackle. They don’t respond to antibiotics, can spread rapidly between human hosts, and even evolve improved ways of working as they multiply. Presenter Marnie Chesterton heads to the University of Oxford’s Nuffield Department of Medi...2020-03-1330 min
Smörgåsbord PodcastEpisode 006: Blah Blah Blood FoodIn today’s episode of Smörgåsbord, Angel and Mik talk about blood. Edible blood. Inspired by a trip to a Filipino restaurant, in search of the blood dish dinuguan, our hosts decide to look more into blood in food all around the world. They explore whether drinking blood is healthy for you and all the kinds of blood food you can eat from different countries. Also, Angel finally tries rice for the first time ever! 00:00 Opening Song 00:43 Show introduction 02:30 Mik discovers a new job 03:13 Real human vampires?! 2019-09-1751 min
VerklighetenSveriges rödaste kommunI Degerfors lockar Vänsterpartiet 35 procent av rösterna. Trots det har partiet förlorat makten för moderatledaren Ulf Kristerssons dröm händer här i Degerfors. Stämningen i kommunen är laddad. Lyssna på alla avsnitt i Sveriges Radio Play. Verkligheten skildrar det delade Sverige i två program – från SD-styrda Hörby till Degerfors.
Medverkande: Johanna Svärd, S. Anna Nordqvist, M. Peter Pedersen, V. Kim Bäckström, V.
Reporter: Sigge Dabrowski2018-11-0617 min
Start the WeekAIDS Activism and Surviving a PlagueOn Start the Week Tom Sutcliffe looks at what happens during a health epidemic and its aftermath. The US activist Peter Staley was instrumental in forcing scientists and pharmaceutical companies to develop life-saving HIV/AIDs drugs. Thirty years later and with drugs now readily available, the concern is that the rate of new cases of HIV remains constant. Professor Anne Johnson was involved in the biggest-ever-official investigation of Britain's sexual habits, which was vetoed at the time by Margaret Thatcher. She says continuing to understand people's attitudes and behaviour is vital to the nation's health. 2016-11-2841 min
NDM Public EngagementScience in a crisis, fast-forwarding clinical research for EbolaProfessor Peter Horby's research focuses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. Professor Peter Horby, who was recently awarded a UK Government Ebola Medal for Service in West Africa for his role in fighting the 2015 Ebola outbreak, talks about the history and science of Ebola. This public lecture was given as part of Oxford Open Doors, on the 12th September 2015.2015-12-0223 min
Translational MedicineEmerging Infectious DiseasesProfessor Peter Horby is Senior Clinical Research Fellow. His research focusses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. Influenza, SARS & Ebola
Research on emerging infectious diseases can only be conducted during outbreaks. Although virology has improved, a well calibrated and effective public health response is often lacking. Epidemiological and clinical research as well as mathematical modelling will give us answers during the epidemics and help us provide better diagnostics and better treatments.2015-03-1106 minTranslational MedicineEmerging Infectious DiseasesProfessor Peter Horby is Senior Clinical Research Fellow. His research focusses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. Influenza, SARS & Ebola
Research on emerging infectious diseases can only be conducted during outbreaks. Although virology has improved, a well calibrated and effective public health response is often lacking. Epidemiological and clinical research as well as mathematical modelling will give us answers during the epidemics and help us provide better diagnostics and better treatments.2015-03-1106 minTranslational MedicineEmerging Infectious DiseasesProfessor Peter Horby is Senior Clinical Research Fellow. His research focusses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. Influenza, SARS & Ebola
Research on emerging infectious diseases can only be conducted during outbreaks. Although virology has improved, a well calibrated and effective public health response is often lacking. Epidemiological and clinical research as well as mathematical modelling will give us answers during the epidemics and help us provide better diagnostics and better treatments.2015-03-1100 min
Epidemics and VaccinesEmerging Infectious DiseasesProfessor Peter Horby is Senior Clinical Research Fellow. His research focusses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. Influenza, SARS & Ebola
Research on emerging infectious diseases can only be conducted during outbreaks. Although virology has improved, a well calibrated and effective public health response is often lacking. Epidemiological and clinical research as well as mathematical modelling will give us answers during the epidemics and help us provide better diagnostics and better treatments.2015-03-1106 min
BBC World Service BusinessClinical trials to find ebola treatment to start next monthThe medical charity Medicins Sans Frontieres will start clinical trials to find an ebola treatment next month. The tests will take place in West Africa and we talked to Dr Peter Horby from Oxford University who is leading one of them. #Ebola2014-11-1304 min
Hundpodden Vår Bästa VänDel 1 - När blev vargen hund? Om hundens ursprung med PeterVart kommer hunden från? När blev vargen hund och vad är skillnaden mellan de? Och hur kommer det sig att 95% av hundarna har samma ursprung när de i utseende och i rasdrag skiljer sig så mycket?
Gurgin snackar med Peter Savolainen, docent inom evolutionär genetik, om hundens ursprung och om vad hans forskarlag från KTH har upptäckt när de undersökt hundens ursprung. Peter menar att man tidigare inte haft några som helst underlag för att säga någonting om hundens ursprung, vetandet har byggt mycket på gissningar...2014-07-1712 minHundpodden Vår Bästa VänDel 2 - När blev vargen hund? Om hundens ursprung med PeterVart kommer hunden från? När blev vargen hund och vad är skillnaden mellan de? Och hur kommer det sig att 95% av hundarna har samma ursprung när de i utseende och i rasdrag skiljer sig så mycket?
Gurgin snackar med Peter Savolainen, docent inom evolutionär genetik, om hundens ursprung och om vad hans forskarlag från KTH har upptäckt när de undersökt hundens ursprung. Peter menar att man tidigare inte haft några som helst underlag för att säga någonting om hundens ursprung, vetandet har byggt mycket på gissningar.2014-07-1710 min